Highlights from ACLC 2024

The 2024 Asia Conference on Lung Cancer (ACLC 2024) took place from October 17 to 19, 2024, in Hong Kong.

Organized by the International Association for the Study of Lung Cancer (IASLC), the conference focused on the latest advancements in lung cancer research, treatment methodologies, and clinical practices.

The conference addressed various topics related to lung cancer, including new research findings and treatment innovations, providing a platform for networking among professionals in the field. It was accredited by the Hong Kong College of Radiologists for CME/CPD points.

Here are some highlights from the event:

IASLC:

“Kicking off ACLC24 in beautiful Hong Kong! An exciting first day filled with brilliant science, valuable networking opportunities, and a whole lot of fun. Let the collaboration continue!”

Hidehito Horinouchi:

“Arriving Hong Kong from Tokyo.

Three reasons to attend:

• Update knowledge on lung cancer
• Great chance to meet APAC colleagues
• Enjoy Hong Kong

I gave it a try like Herbert Loong.”

Herbert Loong:

“A very successful workshop on lung cancer screening implementation before start of IASLC ACLC24: hosted by Asia Pacific Coalition against Lung Cancer, in collaboration with Lung Cancer Policy Network. In depth discussions on key challenges of implementation of LCS across APAC.

More details to follow!

Thanks to our wonderful team.”

Jemma Arakelyan:

“Day 2 ACLC24 Highlights: Had an insightful ‘secret’ focus group discussion!

Thanks, IASLC for the opportunity!”

Xiuning Le:

“Great to see many APAC and global thoracic leaders ACLC24 IASLC in Hong Kong, a beautiful and dynamic city! I also did serious shopping and eating, site seeing and visited the M+ museum.”

Hegi Fiona:

“Our own Kwan Fung talking about the implications of the new 9th Ed staging system for radiation oncology and medical oncology ACLC24. More RT data needed.”

Vivek Tomar:

“Honoured to represent India Lung Cancer patients voice and to do a workshop on Patient Advocacy to empower patient advocates of Asia at Asia Lung Cancer Conference in Hong Kong.

And so great to meet, brainstorm and collaborate with friends and fellow amazing patient advocates and IASLC colleagues. Thank you IASLC for the opportunity and your outstanding support to patient advocates globally.”

Vun-Sin Lim:

“Meet the Editor: it was wonderful to meet these researchers with great enthusiasm and curiosity about all things journal and publications.”

Rachier and Amollo:

“We were well represented at the Africa Construction Law Gala whose theme was centered on African cultures.”

Jemma Arakelyan:

“Had a fantastic first day at ACLC24 in Hong Kong! I enjoyed engaging sessions for young professionals and was inspired by incredible women leaders in oncology. One takeaway that resonated with me was from Dr. Heather Wakelee: ‘I made research my hobby, so I do it in my clinic free time. And I don’t complain about not having a hobby.’

To top it all off, the national dragon dance surprised all the participants and guests at the end! Huge thanks to the organizers for a wonderful day. Excited for what’s ahead!”

IASLC:

“ChiaTai Tianqing Pharmaceuticals (CTTQ) hosted a standing room only symposia at ACLC24 featuring Profs. Caicun Zhou and Baohei Han, Dr. Sie-Kie Au, and Mr. Eric Tse as they discussed disparities in diagnosis and treatment of lung cancer in China.”

Stella Wan:

“50th Anniversary of IASLC – 2024 Asia Conference on Lung Cancer (ACLC).

This year is held in Hong Kong. So much to learn in this 3-Day international conference.”

Kelsey Wood:

“And that’s a wrap on ACLC24! What a gift to work with members who become friends and to support such incredible humans throughout the globe as they continue to advance thoracic cancer research worldwide. Thanks to everyone who joined us in Hong Kong for a successful Asia Conference on Lung Cancer!”

More posts featuring ACLC 2024.